A design comprised HBV carriers/natural clearance subjects as infected group and HBV negative subjects as uninfected group.
No significant effects of potentially regulatory variants in SLC10A1 on HBV infection and clearance were observed.
Functional studies in vitro and ex vivo have provided no evidence for the role of NTCP genetic variants in regulating protein expression levels.